Tata India Pharma & Healthcare Fund (An open ended equity scheme investing in Pharma and Healthcare Services Sector) |
Tata India Pharma & Healthcare Fund (An open ended equity scheme investing in Pharma and Healthcare Services Sector) |
As on 31st May 2024
![]() ![]() |
Primarily focuses on investment in at least 80% of its net assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India.
INVESTMENT OBJECTIVE:The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
DATE OF ALLOTMENT:December 28,2015
FUND MANAGER(S)Meeta Shetty (Managing Since 09-Nov-18 and overall experience of 17 years)
BENCHMARK:Nifty Pharma TRI
NAVDirect - IDCW | 28.6187 |
Direct - Growth | 28.6187 |
Reg - IDCW | 25.0240 |
Reg - Growth | 25.0240 |
FUND SIZE | |
Rs. 899.17 (Rs. in Cr.) | |
MONTHLY AVERAGE AUM | |
Rs. 905.92 (Rs. in Cr.) | |
TURN OVER | |
Portfolio Turnover (Equity component only) | 22.57% |
EXPENSE RATIO** | |
Direct | 0.83 |
Regular | 2.25 |
**Note: The rates specified are actual month end expenses charged as on May 31, 2024. The above ratio includes the Service tax on Investment Management Fees. The above ratio excludes, borrowing cost, wherever applicable. |
VOLATILITY MEASURES^ | FUND | BENCHMARK |
Std. Dev (Annualised) | 14.23 | 14.92 |
Sharpe Ratio | 0.57 | 0.32 |
Portfolio Beta | 0.88 | NA |
R Squared | 0.90 | NA |
Treynor | 0.77 | NA |
Jenson | 0.32 | NA |
^Risk-free rate based on the FBIL Overnight MIBOR rate of 6.76% as
on May 31, 2024 For calculation methodology |
Rs. 5,000/- and in multiples of Re. 1/- thereafter.
ADDITIONAL INVESTMENT/Rs. 1,000/- and multiples of Re. 1/- thereafter.
LOAD STRUCTURE:ENTRY LOAD | Not Applicable |
EXIT LOAD | 0.25% of NAV if redeemed/switched out
before 30 days from the date of allotment. |
Company Name | No. of Shares | Market Value Rs Lakhs | % of assets |
Equity & Equity Related Total | 87139.98 | 96.95 | |
Chemicals & Petrochemicals | |||
Deepak Nitrite Ltd. | 17909 | 392.44 | 0.44 |
Fertilizers & Agrochemicals | |||
Coromandel International Ltd. | 60000 | 784.38 | 0.87 |
Healthcare Services | |||
Fortis Healthcare Ltd. | 855100 | 4062.58 | 4.52 |
Apollo Hospitals Enterprise Ltd. | 58903 | 3439.46 | 3.83 |
Healthcare Global Enterprises Ltd. | 566121 | 2042.28 | 2.27 |
Jupiter Life Line Hospitals Ltd. | 106389 | 1251.77 | 1.39 |
Aster Dm Healthcare Ltd. | 264625 | 963.10 | 1.07 |
Syngene International Ltd. | 107046 | 719.46 | 0.80 |
Insurance | |||
Medi Assist Healthcare Services Ltd. | 418670 | 2057.55 | 2.29 |
Pharmaceuticals & Biotechnology | |||
Sun Pharmaceutical Industries Ltd. | 804300 | 11741.17 | 13.06 |
Aurobindo Pharma Ltd. | 741000 | 8786.04 | 9.77 |
Lupin Ltd. | 510240 | 8074.80 | 8.98 |
Dr Reddys Laboratories Ltd. | 107643 | 6234.52 | 6.93 |
Cipla Ltd. | 415000 | 6005.88 | 6.68 |
Zydus Lifesciences Ltd. | 471287 | 4713.58 | 5.24 |
Divi Laboratories Ltd. | 104965 | 4521.05 | 5.03 |
Alkem Laboratories Ltd. | 75249 | 3619.82 | 4.03 |
Ajanta Pharma Ltd. | 95614 | 2230.82 | 2.48 |
Fdc Ltd. | 471283 | 2038.30 | 2.27 |
Torrent Pharmaceuticals Ltd. | 70921 | 1912.07 | 2.13 |
Orchid Pharma Ltd. | 175000 | 1754.73 | 1.95 |
Sanofi India Ltd. | 19164 | 1653.34 | 1.84 |
Ipca Laboratories Ltd. | 142452 | 1641.26 | 1.83 |
Wockhardt Ltd. | 193423 | 1023.88 | 1.14 |
Mankind Pharma Ltd. | 41446 | 886.84 | 0.99 |
Piramal Pharma Ltd. | 596702 | 883.42 | 0.98 |
Indoco Remedies Ltd. | 276851 | 831.80 | 0.93 |
Procter & Gamble Health Ltd. | 16000 | 752.14 | 0.84 |
Glaxosmithkline Pharmaceuticals Ltd. | 24588 | 644.03 | 0.72 |
Ami Organics Ltd. | 50000 | 608.63 | 0.68 |
Retailing | |||
Medplus Health Services Ltd. | 118808 | 868.84 | 0.97 |
Repo | 262.41 | 0.29 | |
Portfolio Total | 87402.39 | 97.24 | |
Cash / Net Current Asset | 2514.74 | 2.76 | |
Net Assets | 89917.13 | 100.00 |
Issuer Name | % to NAV |
Sun Pharmaceutical Industries Ltd. | 13.06 |
Aurobindo Pharma Ltd. | 9.77 |
Lupin Laboratories Ltd. | 8.98 |
Dr. Reddys Labaratories Ltd. | 6.93 |
Cipla Ltd. | 6.68 |
Zydus Lifesciences Ltd. | 5.24 |
Divi Laboratories Ltd. | 5.03 |
Fortis Healthcare Ltd. | 4.52 |
Alkem Laboratories Ltd. | 4.03 |
Apollo Hospitals Enterprise Ltd. | 3.83 |
Total | 68.07 |
Large Cap | 39.87% |
Mid Cap | 40.93% |
Small Cap | 19.20% |
Market Capitalisation is as per list provided by AMFI. |